OPKO Health SG&A Expenses 2010-2025 | OPK

OPKO Health sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
OPKO Health Annual SG&A Expenses
(Millions of US $)
2024 $304
2023 $301
2022 $373
2021 $469
2020 $356
2019 $343
2018 $358
2017 $415
2016 $407
2015 $197
2014 $58
2013 $55
2012 $28
2011 $19
2010 $18
2009 $10
OPKO Health Quarterly SG&A Expenses
(Millions of US $)
2025-03-31 $59
2024-12-31 $67
2024-09-30 $98
2024-06-30 $69
2024-03-31 $70
2023-12-31 $73
2023-09-30 $72
2023-06-30 $80
2023-03-31 $76
2022-12-31 $74
2022-09-30 $80
2022-06-30 $101
2022-03-31 $118
2021-12-31 $138
2021-09-30 $105
2021-06-30 $113
2021-03-31 $112
2020-12-31 $102
2020-09-30 $100
2020-06-30 $78
2020-03-31 $76
2019-12-31 $79
2019-09-30 $81
2019-06-30 $88
2019-03-31 $95
2018-12-31 $95
2018-09-30 $84
2018-06-30 $88
2018-03-31 $92
2017-12-31 $96
2017-09-30 $103
2017-06-30 $106
2017-03-31 $110
2016-12-31 $165
2016-09-30 $125
2016-06-30 $118
2016-03-31
2015-12-31 $103
2015-09-30 $55
2015-06-30 $21
2015-03-31 $17
2014-12-31 $15
2014-09-30 $14
2014-06-30 $15
2014-03-31 $14
2013-12-31 $15
2013-09-30 $14
2013-06-30 $14
2013-03-31 $12
2012-12-31 $10
2012-09-30 $7
2012-06-30 $5
2012-03-31 $5
2011-12-31 $5
2011-09-30 $4
2011-06-30 $5
2011-03-31 $5
2010-12-31 $4
2010-09-30 $4
2010-06-30 $6
2010-03-31 $4
2009-12-31 $1
2009-09-30 $3
2009-06-30 $3
2009-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.007B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $184.618B 80.86
Thermo Fisher Scientific (TMO) United States $151.077B 18.27
Edwards Lifesciences (EW) United States $44.183B 28.97
IDEXX Laboratories (IDXX) United States $42.193B 48.49
Alcon (ALC) Switzerland $42.098B 28.45
DexCom (DXCM) United States $31.306B 48.39
IQVIA Holdings (IQV) United States $26.844B 15.04
Mettler-Toledo (MTD) United States $24.183B 28.76
STERIS (STE) Ireland $23.305B 25.67
Waters (WAT) United States $20.402B 28.78
SONOVA HOLDING (SONVY) Switzerland $17.717B 0.00
Hologic (HOLX) United States $14.358B 15.60
Sysmex ADR (SSMXY) Japan $10.777B 30.57
Penumbra (PEN) United States $9.854B 77.34
Masimo (MASI) United States $9.115B 33.62
Globus Medical (GMED) United States $7.826B 18.65
Glaukos (GKOS) United States $5.531B 0.00
Teleflex (TFX) United States $5.217B 8.61
TransMedics (TMDX) United States $4.314B 93.77
Integer Holdings (ITGR) United States $4.155B 21.77
PROCEPT BioRobotics (PRCT) United States $3.250B 0.00
LivaNova (LIVN) United Kingdom $2.485B 14.80
Nihon Kohden (NHNKY) Japan $2.265B 25.98
Veracyte (VCYT) United States $2.092B 29.35
Elekta AB (EKTAY) Sweden $1.872B 16.83
Alphatec Holdings (ATEC) United States $1.587B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.317B 123.40
Pulse Biosciences (PLSE) United States $1.042B 0.00
Integra LifeSciences Holdings (IART) United States $0.903B 4.80
IRadimed (IRMD) United States $0.756B 38.38
SiBone (SIBN) United States $0.704B 0.00
Beta Bionics (BBNX) United States $0.685B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.560B 8.71
RxSight (RXST) United States $0.550B 0.00
Mesa Laboratories (MLAB) United States $0.534B 12.52
OrthoPediatrics (KIDS) United States $0.500B 0.00
Semler Scientific (SMLR) United States $0.468B 12.46
Delcath Systems (DCTH) United States $0.462B 0.00
AxoGen (AXGN) United States $0.446B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.423B 0.00
AngioDynamics (ANGO) United States $0.406B 0.00
Treace Medical Concepts (TMCI) United States $0.361B 0.00
Pacific Biosciences Of California (PACB) United States $0.357B 0.00
NeuroPace (NPCE) United States $0.347B 0.00
ClearPoint Neuro (CLPT) United States $0.318B 0.00
908 Devices (MASS) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.32
Neuronetics (STIM) United States $0.226B 0.00
Sight Sciences (SGHT) United States $0.224B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Biosig Technologies (BSGM) United States $0.203B 0.00
Inogen (INGN) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
CVRx (CVRX) United States $0.149B 0.00
LENSAR (LNSR) United States $0.144B 0.00
Rapid Micro Biosystems (RPID) United States $0.139B 0.00
Anteris Technologies Global (AVR) Australia $0.137B 0.00
Accuray (ARAY) United States $0.129B 0.00
Lucid Diagnostics (LUCD) United States $0.129B 0.00
Atossa Genetics (ATOS) United States $0.103B 0.00
Monogram Orthopaedics (MGRM) United States $0.101B 0.00
Microbot Medical (MBOT) United States $0.086B 0.00
InspireMD (NSPR) United States $0.077B 0.00
Sensus Healthcare (SRTS) United States $0.076B 46.00
EnVVeno Medical (NVNO) United States $0.072B 0.00
EDAP TMS S.A (EDAP) France $0.064B 0.00
Hyperfine (HYPR) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Baird Medical Investment Holdings (BDMD) $0.038B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
NexGel (NXGL) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
PAVmed (PAVM) United States $0.010B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Ekso Bionics Holdings (EKSO) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.51
Spinal Elements Holdings (SPEL) United States $0.000B 0.00